French adopt tax increase on medtech sales, as financing bill clears lower house
This article was originally published in SRA
The tax that medtech companies must pay for products sold in France will rise from 0.25% of the revenue they generate in the country to 0.29% as of next year1.
You may also be interested in...
While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers the tests are not sufficiently accurate to be used in the pandemic.
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.